Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Sather

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|November 7, 1991
Second neoplasms after acute lymphoblastic leukemia in childhoodJ P Neglia, A T Meadows, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study GroupA E Evans, G J D'Angio, H N Sather, et al.
Leukemia & Lymphoma|February 26, 1999
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID miceB J Waurzyniak, N Heerema, M G Sensel, et al.
Medical and Pediatric Oncology|January 1, 1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group studyW R Balsom, W A Bleyer, L L Robison, et al.
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
The New England Journal of Medicine|June 6, 1998
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyJ B Nachman, H N Sather, M G Sensel, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimenW A Bleyer, P F Coccia, H N Sather, et al.
Leukemia|March 3, 2004
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemiaJ P Perentesis, S Bhatia, E Boyle, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1988
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193PP S Gaynon, W A Bleyer, P G Steinherz, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|November 7, 1991
Second neoplasms after acute lymphoblastic leukemia in childhoodJ P Neglia, A T Meadows, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study GroupA E Evans, G J D'Angio, H N Sather, et al.
Leukemia & Lymphoma|February 26, 1999
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID miceB J Waurzyniak, N Heerema, M G Sensel, et al.
Medical and Pediatric Oncology|January 1, 1991
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group studyW R Balsom, W A Bleyer, L L Robison, et al.
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
The New England Journal of Medicine|June 6, 1998
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyJ B Nachman, H N Sather, M G Sensel, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimenW A Bleyer, P F Coccia, H N Sather, et al.
Leukemia|March 3, 2004
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemiaJ P Perentesis, S Bhatia, E Boyle, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1988
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193PP S Gaynon, W A Bleyer, P G Steinherz, et al.
Pageof 9